GlassScriptPhysician profile
Leonard T Carr
NPI 1134279862
$4,330.87
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,713 · 2020: $1,675 · 2021: $920 · 2022: $22.34.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $510.76 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $496.28 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $434.91 | 2019-2022 | |
| Allergan, INC. | $420.96 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $347.25 | 2019-2021 | |
| Lundbeck LLC | $262.05 | 2019-2021 | |
| Adlon Therapeutics L.P. | $239.52 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $222.87 | 2019-2021 | |
| Abbvie INC. | $170.83 | 2021 | |
| Shire North American Group INC | $162.87 | 2019 | |
| Ironshore Pharmaceuticals INC. | $149.41 | 2019-2020 | |
| Neos Therapeutics, LP | $147.19 | 2019-2020 | |
| Neuronetics, INC. | $132.99 | 2019 | |
| Vanda Pharmaceuticals INC. | $132.52 | 2019 | |
| Avanir Pharmaceuticals, INC. | $111.61 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $105.22 | 2019-2021 | |
| Owp Pharmaceuticals, INC. | $76.12 | 2019 | |
| Bausch Health US, LLC | $67.08 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $66.99 | 2021 | |
| Alfasigma USA, INC. | $28.94 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $26.40 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.10 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.